Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Seema A. Bhat is a hematologist who specializes in treating patients with chronic lymphocytic leukemia (CLL). She was excited to join the OSUCCC – James because of the cutting-edge and exemplary work done by the Leukemia Research program, which has transformed the treatment approach for patients with CLL, leading to the approval of more effective and innovative treatments for this disease. The James is leading the race to cure CLL, and she is honored to be a member of that team as a clinical investigator focusing on designing and leading clinical trials. Dr. Bhat has served as a principal investigator on a number of clinical trials, and she also collaborates with laboratory scientists to develop novel therapies for CLL. Her research interests include developing novel targeted therapies for the treatment of CLL with the goal of curing this disease without the need of chemotherapy. She aims to improve the quality of life for these patients so that they can lead a normal and productive life without enduring the toxic effects of treatment. In addition to my clinical work, she is an assistant professor in the Department of Internal Medicine, Division of Hematology at The Ohio State University and has served on a number of national committees, including the NCCN Guidelines panels for cancer- and chemotherapy-induced anemia, chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia. Dr. Bhat feels privileged to be part of OSUCCC – The James. They believe in providing personalized care for each patient to ensure better outcomes, and it’s truly rewarding to contribute to this medical and academic community as they work toward our common goal of a cancer-free world.